DALLAS--(BUSINESS WIRE)--Starlight Therapeutics— a Lantern Pharma (Nasdaq: LTRN) subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers ...
Study maps five major eras of brain wiring from birth to old age, revealing the key turning points that shape how we learn, ...
HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...
Vect-Horus has a clinical-phase solution to a key drug development challenge: crossing the blood–brain barrier (BBB). By targeting receptors on the barrier, Vect-Horus is empowering partners such as ...
Cold Spring Harbor Laboratory postdoc Stan Kerstjens and colleagues have devised a new theory for how the brain organizes ...
Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics, Inc. ...
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it is ...
PsyPost on MSN
Study links parents’ perceived financial strain to delayed brain development in infants
A study of infants during their first year of life found that those coming from households where parents felt their income was inadequate to support the family’s needs tended to show delayed brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results